During the month, BSE received 463 complaints against 200 companies. In the same period 344 complaints were resolved against 156 listed companies. These resolved complaints include complaints brought forward from the previous periods.
The complaints received by BSE from Investors have been categorized as under:
Type I Non-receipt of money (Refund, Interest, Redemption, Fractional Entitlement.) Type II : Non-receipt of Equity shares ( Demat & Physical : In Public/Rights issue,Remat, Transfer, Transmission, Conversion / Endorsement / Consolidation/Splitting / Duplicate Certificate) Type III Non-receipt of Debt Securities ( Demat & Physical : In Public/Rights issue,Remat, Transfer, Transmission, Conversion / Endorsement / Consolidation/Splitting / Duplicate Certificate) Type IV Non-receipt of Corporate benefits / entitlements ( Dividend, Bonus, Rights form, Buyback letter of offer, Delisting letter of offer, Annual Report ) Type V Non-receipt of Interest for delay in : ( Refunds, Dividend, Interest on debt security, Redemption of debt security , Securities ) Type VI Others ( Including Non-Adherence to Corporate Governance Norms )
Below table shows highest number of complaints pending against suspended companies as on 3 rd May, 2021.
Sr. No. Company Name Category Number of complaints pending as on 03/05/2021 1 J.K. Pharmachem Ltd. X 16 2 Gujarat Narmada Flyash Co. Ltd. XT 12 3 Teem Laboratories Ltd. X 12 4 Gujarat Perstorp Electronics Ltd P 12 5 Saptak Chem And Business Limited Z 11 6 Gujarat Meditech Ltd Z 11 7 Blazon Marbles Limited X 11 8 Global Securities Limited XT 10 9 Softrak Venture Investments Ltd. X 9 10 Willard India Ltd. XT 9
These aforesaid companies are presently suspended at the Exchange for surveillance reasons/ certain non-compliances with the listing regulations/procedural reasons or as per operation of law.